NAKA Quote, Financials, Valuation and Earnings

Pediatrix Medical Group, Inc. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of 14.55%. Kindly MD, Inc.'s return on equity of -91.57% beat Pediatrix Medical Group, Inc.'s return on equity of 20.22%.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 126.86%. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $22.67 which suggests that it could grow by 1.69%. Given that Kindly MD, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe Kindly MD, Inc. is more attractive than Pediatrix Medical Group, Inc..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.766, suggesting its less volatile than the S&P 500 by 23.447%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than Pediatrix Medical Group, Inc. quarterly revenues of $492.9M. Kindly MD, Inc.'s net income of -$86M is lower than Pediatrix Medical Group, Inc.'s net income of $71.7M. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while Pediatrix Medical Group, Inc.'s PE ratio is 11.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 15.44x versus 0.99x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

SRx Health Solutions, Inc. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of -13.47%. Kindly MD, Inc.'s return on equity of -91.57% beat SRx Health Solutions, Inc.'s return on equity of --.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 126.86%. On the other hand SRx Health Solutions, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Kindly MD, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe Kindly MD, Inc. is more attractive than SRx Health Solutions, Inc..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SRx Health Solutions, Inc. has a beta of 0.929, suggesting its less volatile than the S&P 500 by 7.069%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SRx Health Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. SRx Health Solutions, Inc. pays out -- of its earnings as a dividend.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than SRx Health Solutions, Inc. quarterly revenues of $7.2M. Kindly MD, Inc.'s net income of -$86M is lower than SRx Health Solutions, Inc.'s net income of -$964K. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while SRx Health Solutions, Inc.'s PE ratio is 0.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 15.44x versus 0.07x for SRx Health Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute, Inc. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of -10.08%. Kindly MD, Inc.'s return on equity of -91.57% beat The Oncology Institute, Inc.'s return on equity of -9486.64%.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 126.86%. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 111.73%. Given that Kindly MD, Inc. has higher upside potential than The Oncology Institute, Inc., analysts believe Kindly MD, Inc. is more attractive than The Oncology Institute, Inc..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.162, suggesting its less volatile than the S&P 500 by 83.817%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than The Oncology Institute, Inc. quarterly revenues of $136.6M. Kindly MD, Inc.'s net income of -$86M is lower than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 15.44x versus 0.57x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

U.S. Physical Therapy, Inc. has a net margin of -22162.75% compared to Kindly MD, Inc.'s net margin of 9.98%. Kindly MD, Inc.'s return on equity of -91.57% beat U.S. Physical Therapy, Inc.'s return on equity of 8.6%.

Kindly MD, Inc. has a consensus price target of $1.25, signalling upside risk potential of 126.86%. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.17 which suggests that it could grow by 39.68%. Given that Kindly MD, Inc. has higher upside potential than U.S. Physical Therapy, Inc., analysts believe Kindly MD, Inc. is more attractive than U.S. Physical Therapy, Inc..

Kindly MD, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.320, suggesting its more volatile than the S&P 500 by 32.001%.

Kindly MD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. U.S. Physical Therapy, Inc. offers a yield of 2.39% to investors and pays a quarterly dividend of $0.45 per share. Kindly MD, Inc. pays -- of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 95.62% of its earnings as a dividend. U.S. Physical Therapy, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Kindly MD, Inc. quarterly revenues are $388.2K, which are smaller than U.S. Physical Therapy, Inc. quarterly revenues of $197.1M. Kindly MD, Inc.'s net income of -$86M is lower than U.S. Physical Therapy, Inc.'s net income of $19.7M. Notably, Kindly MD, Inc.'s price-to-earnings ratio is -- while U.S. Physical Therapy, Inc.'s PE ratio is 31.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD, Inc. is 15.44x versus 1.51x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.